Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Interchangeable Biosimilars May Qualify For ‘Immediate Substitution’ In Medicare Part D
Dec 15 2022
•
By
Cathy Kelly
Immediate Substitution Not Allowed For Non-Interchangeable Biosimilars • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images
More from Biosimilars
More from Biosimilars & Generics